|
US6268392B1
(en)
*
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
WO1997016184A1
(en)
*
|
1995-11-02 |
1997-05-09 |
Warner-Lambert Company |
Method and pharmaceutical composition for regulating lipid concentration
|
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
|
GT199800126A
(es)
*
|
1997-08-29 |
2000-01-29 |
|
Terapia de combinacion.
|
|
EP1514543A1
(en)
*
|
1997-08-29 |
2005-03-16 |
Pfizer Inc. |
Combination therapy comprising atorvastatin and an antihypertensive agent
|
|
BR9815745A
(pt)
*
|
1998-03-17 |
2000-11-14 |
Warner Lambert Co |
Combinações de inibidor de metaloproteinase de matriz estatina
|
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
CZ20011035A3
(cs)
*
|
1998-09-30 |
2001-10-17 |
Warner-Lambert Company |
Léčivo pro prevenci nebo oddálení revaskularizace pomocí katetru u pacientů postiľených chorobou koronární artérie
|
|
CO5140104A1
(es)
|
1999-02-16 |
2002-03-22 |
Novartis Ag |
Derivados de mevinolina y preparacion farmaceuticas que los contienen
|
|
US20010006656A1
(en)
*
|
1999-02-17 |
2001-07-05 |
University Of Washington |
Methods and compositions for inhibiting inflammation associated with pulmonary disease
|
|
AU7717500A
(en)
*
|
1999-09-30 |
2001-04-30 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
EP1092432A1
(fr)
|
1999-10-15 |
2001-04-18 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) |
Composes anti-ischemiques
|
|
WO2001034127A1
(en)
*
|
1999-11-05 |
2001-05-17 |
Warner-Lambert Company |
Prevention of plaque rupture by acat inhibitors
|
|
MXPA03001857A
(es)
*
|
2000-09-01 |
2003-06-04 |
Sankyo Co |
Composicones medicinales.
|
|
AU2002211666A1
(en)
|
2000-10-11 |
2002-04-22 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
WO2002030860A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US20040122091A1
(en)
*
|
2000-10-11 |
2004-06-24 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003024A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
|
|
US7304093B2
(en)
*
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
IL155215A0
(en)
|
2000-10-11 |
2003-11-23 |
Esperion Therapeutics Inc |
Ether compounds and compositions for cholesterol management and related uses
|
|
CA2369967A1
(en)
*
|
2001-02-12 |
2002-08-12 |
Joseph Anthony Cornicelli |
Methods of treating nuclear factor-kappa b mediated diseases and disorders
|
|
PE20030324A1
(es)
*
|
2001-07-31 |
2003-04-03 |
Warner Lambert Co |
Composiciones farmaceuticas de amlodipina y atorvastatina
|
|
US20040192771A1
(en)
*
|
2001-10-11 |
2004-09-30 |
Dasseux Jean-Louis Henri |
Ether compounds and compositions for cholesterol management and related uses
|
|
US20050020694A1
(en)
*
|
2001-10-11 |
2005-01-27 |
Dasseux Jean-Louis Henri |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
US20040204502A1
(en)
*
|
2001-10-11 |
2004-10-14 |
Dasseux Jean-Louis Henri |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
CA2478184A1
(en)
*
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Drug combination therapy
|
|
US20030236212A1
(en)
*
|
2002-04-10 |
2003-12-25 |
Jean-Louis Dasseux |
Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses
|
|
JP4187141B2
(ja)
*
|
2002-04-12 |
2008-11-26 |
興和株式会社 |
新規なトロンボモジュリン発現促進剤
|
|
HUE036646T2
(hu)
*
|
2003-01-23 |
2018-07-30 |
Esperion Therapeutics Inc |
Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra
|
|
KR20060111898A
(ko)
|
2003-08-29 |
2006-10-30 |
교와 가부시키가이샤 |
지질-풍부-플라크의 안정화 방법 및 파열 예방방법
|
|
EP1688140A1
(en)
*
|
2003-11-17 |
2006-08-09 |
Toyo Shinyaku Co., Ltd. |
Lipometabolism improver containing pine bark extract
|
|
JP2007525408A
(ja)
*
|
2003-12-24 |
2007-09-06 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理および関連使用のためのケトン化合物および組成物
|
|
WO2005102348A1
(en)
*
|
2004-04-19 |
2005-11-03 |
Loma Linda University |
Composition and method of decreasing renal ischemic damage
|
|
TW200605890A
(en)
*
|
2004-07-28 |
2006-02-16 |
Sankyo Co |
Pharmaceutical compositions for inhibiting arteriosclerosis
|
|
TW200619191A
(en)
*
|
2004-10-27 |
2006-06-16 |
Sankyo Co |
Phenyl compounds with more than 2 substitutes
|
|
TW200619204A
(en)
*
|
2004-12-10 |
2006-06-16 |
Kowa Co |
Method for reduction, stabilization and prevention of rupture of lipid rich plaque
|
|
CA2627599A1
(en)
*
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
|
|
RU2308947C1
(ru)
*
|
2006-02-26 |
2007-10-27 |
Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) |
Лекарственное средство с гиполипидемическим эффектом "симваглизин"
|
|
PT2018153E
(pt)
|
2006-04-26 |
2012-07-04 |
Rosemont Pharmaceuticals Ltd |
Composições orais líquidas
|
|
US20130254787A1
(en)
|
2006-05-02 |
2013-09-26 |
Invidi Technologies Corporation |
Method and apparatus to perform real-time audience estimation and commercial selection suitable for targeted advertising
|
|
US20070269503A1
(en)
*
|
2006-05-16 |
2007-11-22 |
James Walter Burgess |
Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
|
|
US8314080B2
(en)
|
2010-04-06 |
2012-11-20 |
Kuwait University |
Method of treating type I diabetes
|
|
CN103274985B
(zh)
*
|
2010-12-03 |
2016-03-09 |
上海科州药物研发有限公司 |
一种阿托伐他汀氨基酸盐
|
|
US8586527B2
(en)
*
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
|
CN104023727B
(zh)
|
2011-10-28 |
2017-04-05 |
鲁美纳医药公司 |
用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
|
|
CA2852957C
(en)
|
2011-10-28 |
2020-08-04 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
|
|
CN103304496A
(zh)
*
|
2012-03-08 |
2013-09-18 |
南京工业大学 |
一种合成申嗪霉素方法
|
|
US10047034B2
(en)
|
2012-05-16 |
2018-08-14 |
Prairie Berry Europe Gmbh |
Polyhydroxylated pentacyclic triterpene acids as HMG-COA reductase inhibitors
|
|
RU2022102472A
(ru)
|
2015-03-13 |
2022-03-15 |
Эсперион Терапеутикс, Инк. |
Фиксированные комбинации и составы, содержащие etc-1002 и эзетимиб, и способы лечения или уменьшения риска развития сердечно-сосудистого заболевания
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
CN112437766A
(zh)
|
2019-06-21 |
2021-03-02 |
艾斯柏伦治疗公司 |
制备贝派地酸及其组合物的方法
|